Protease Inhibitor May Aid In Diabetic Retinopathy Treatment
Saturday, January 24, 2009 - 18:21
in Health & Medicine
Researchers have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440 may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.